Friday, 19 Jul 2019

You are here

Proinflammatory Diets May Increase CRP and RA Onset

Despite the lack of good evidence, there has been great speculation about the role of diet in causing or alleviating inflammation. Now there's new research suggesting that proinflammatory diets can increase serum C-reactive protein (CRP) levels and also the risk of RA onset.

This study used a dietary survey called Dietary Inflammatory Index (DII) as a measure of dietary substances capable of augmenting inflammatory biomarkers. Diets with a high DII scores are associated with increased levels of CRP and interleukin-6. 

Patients in two large prospective registries, the European Prospective Investigation of Cancer (EPIC) and the Norfolk Arthritis Register (NOAR) were studied after linking databases.

The DII was calculated on healthy subjected being enrolled into EPIC between 1993 and 1998. Among the 25,522 EPIC patients they identified 159 who were subsequently diagnosed as RA from the NOAR registry. 

Comparison of highest and lowest quartiles of DII from EPIC enrollment revealed that high DII scores (proinflammatory diets) were associated with a higher risk of subsequent RA onset (DII: OR 1.90 [1.21-3.02]; p < 0.01).  However, when these analyses were adjusted for age, sex and BMI, the same level  significance was not achieved (OR 1.35 [0.85-2.19]; p = 0.2).

Diet may be one of the few modifiable factors that may influence inflammation and the risk of future RA onset. 

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

Upadacitinib Superior to Adalimumab in Methotrexate Refractory RA

Upadacitinib, a JAK1-selective inhibitor, was studied head to head against adalimumab and placebo in rheumatoid arthritis after an inadequate response to methotrexate, and shown to be superior to ADA and PBO in ACR20 and DAS remission level responses.

CRP Utility in COPD Exacerbations

NEJM reports on the utility of C-reactive protein (CRP) testing in chronic obstructive pulmonary disease (COPD) patients, showing that CRP guided prescribing of antibiotics for exacerbations of COPD in primary care clinics resulted in a lower percentage of patients who reported antibiotic use.

EULAR 2019 - Day 1 Report

Editor's note: July 1 - 5, RheumNow is running the best of the EULAR 2019 meeting. Here are a few of the highlights from day 1 EULAR in Madrid, including another IL-23 inhibitor, BTK inhibition, abatacept in Sjogren's syndrome, don't repeat the ANA, and drug free remission in systemic JIA.

Borrelia burgdorferi Peptidoglycan Shedding Drives Lyme Arthritis

Research published in PNAS has shown that long after active Lyme infection in the joint, a peptidoglycan (PG) of the the spirochete Borrelia burgdorferi can be found in the joints of those with late-stage Lyme disease.

 

EULAR 2019 - Day 1 Report

Here are a few of the highlights from day 1 EULAR in Madrid.